Education
About Us
Working with TipRanks
Follow Us
Cellebrite DI (CLBT)
NASDAQ:CLBT
CLBT Analyst Ratings
Strong Buy
8 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CLBT Stock 12 Month Forecast
Average Price Target
$21.67
▲(25.55% Upside)
| Highest Price Target$25.00 | Average Price Target$21.67 | Lowest Price Target$18.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TD Cowen
$25
Buy
44.84%
Upside
Reiterated
09/18/25
J.P. Morgan
$20
Buy
15.87%
Upside
Reiterated
09/09/25
William Blair
―
Buy
―
Reiterated
09/04/25
Cellebrite DI's Strategic Growth and Market Expansion: Analyst Recommends Buy RatingWe hosted a fireside chat with Cellebrite CEO Tom Hogan and CFO David Barter. Hogan and Barter conveyed how the mission criticality of Cellebrite’s software and Cellebrite’s industry leadership were major considerations when assuming their current roles. Hogan indicated that he would not have moved into the permanent CEO role (announced on August 14 earnings call) if he thought Cellebrite’s best days were in the past. Hogan and Barter discussed how they see the potential for Cellebrite to “take it to the next level” in terms of expanding into adjacent markets. Hogan reiterated his high-level view that there is the potential for a 2026 resurgence. The presentation provided more details on the Corellium acquisition. Cellebrite already closed a deal under a reseller agreement even though the acquisition has not closed.
Craig-Hallum
―
Buy
―
Reiterated
08/26/25
TR | OpenAI - 4o
$17.5→$16
Hold
-7.30%
Downside
Reiterated
08/20/25
AI Generated ArticleAI Generated Article
Deutsche Bank
$24→$21
Buy
21.67%
Upside
Reiterated
08/15/25
Lake Street
$24→$22
Buy
27.46%
Upside
Reiterated
08/15/25
Needham
$24→$18
Buy
4.29%
Upside
Reiterated
08/14/25
Bank of America Securities
$25→$24
Buy
39.05%
Upside
Reiterated
08/14/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
$25
Buy
44.84%
Upside
Reiterated
09/18/25
J.P. Morgan
$20
Buy
15.87%
Upside
Reiterated
09/09/25
William Blair
―
Buy
―
Reiterated
09/04/25
Cellebrite DI's Strategic Growth and Market Expansion: Analyst Recommends Buy RatingWe hosted a fireside chat with Cellebrite CEO Tom Hogan and CFO David Barter. Hogan and Barter conveyed how the mission criticality of Cellebrite’s software and Cellebrite’s industry leadership were major considerations when assuming their current roles. Hogan indicated that he would not have moved into the permanent CEO role (announced on August 14 earnings call) if he thought Cellebrite’s best days were in the past. Hogan and Barter discussed how they see the potential for Cellebrite to “take it to the next level” in terms of expanding into adjacent markets. Hogan reiterated his high-level view that there is the potential for a 2026 resurgence. The presentation provided more details on the Corellium acquisition. Cellebrite already closed a deal under a reseller agreement even though the acquisition has not closed.
Craig-Hallum
―
Buy
―
Reiterated
08/26/25
TR | OpenAI - 4o
$17.5→$16
Hold
-7.30%
Downside
Reiterated
08/20/25
AI Generated ArticleAI Generated Article
Deutsche Bank
$24→$21
Buy
21.67%
Upside
Reiterated
08/15/25
Lake Street
$24→$22
Buy
27.46%
Upside
Reiterated
08/15/25
Needham
$24→$18
Buy
4.29%
Upside
Reiterated
08/14/25
Bank of America Securities
$25→$24
Buy
39.05%
Upside
Reiterated
08/14/25
Best Analysts Covering Cellebrite DI
1 Month
xxx
Success Rate
11/18 ratings generated profit
Average Return
+3.18%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 61.11% of your transactions generating a profit, with an average return of +3.18% per trade.
3 Months
xxx
Success Rate
17/25 ratings generated profit
Average Return
+12.57%
reiterated a xxx
rating 24 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 68.00% of your transactions generating a profit, with an average return of +12.57% per trade.
1 Year
Success Rate
17/25 ratings generated profit
Average Return
+48.81%
reiterated a buy rating 24 days ago
Copying Jeff Van Rhee's trades and holding each position for 1 Year would result in 68.00% of your transactions generating a profit, with an average return of +48.81% per trade.
2 Years
xxx
Success Rate
21/29 ratings generated profit
Average Return
+62.64%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 72.41% of your transactions generating a profit, with an average return of +62.64% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CLBT Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
3
1
2
4
4
Buy
15
20
17
16
10
Hold
7
5
7
8
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
26
26
28
21
Each month's total comprises the sum of three months' worth of ratings.
CLBT Financial Forecast
CLBT Stock Forecast FAQ
What is CLBT’s average 12-month price target, according to analysts?
Based on analyst ratings, Cellebrite DI’s 12-month average price target is 21.67.
What is CLBT’s upside potential, based on the analysts’ average price target?
Cellebrite DI has 25.55% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CLBT a Buy, Sell or Hold?
Cellebrite DI has a consensus rating of Strong Buy which is based on 8 buy ratings, 0 hold ratings and 0 sell ratings.
What is Cellebrite DI’s price target?
The average price target for Cellebrite DI is 21.67. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $25.00 ,the lowest forecast is $18.00. The average price target represents 25.55% Increase from the current price of $17.26.
The highest analyst price target is $25.00 ,the lowest forecast is $18.00. The average price target represents 25.55% Increase from the current price of $17.26.
What do analysts say about Cellebrite DI?
Cellebrite DI’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of CLBT?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.